Get the Stockscreener App
7.49
3.60%
0.26
Tempest Therapeutics Inc stock is traded at $7.49, with a volume of 28,947.
It is up +3.60% in the last 24 hours and up +8.55% over the past month.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
See More
Previous Close:
$7.23
Open:
$7.1501
24h Volume:
28,947
Relative Volume:
0.25
Market Cap:
$27.58M
Revenue:
-
Net Income/Loss:
$-31.11M
P/E Ratio:
-4.8954
EPS:
-1.53
Net Cash Flow:
$-28.18M
1W Performance:
-3.48%
1M Performance:
+8.55%
6M Performance:
-37.03%
1Y Performance:
-66.31%
1-Day Range:
$7.045
$7.49
1-Week Range:
$7.045
$8.75
52-Week Range:
$5.3495
$28.34
Tempest Therapeutics Inc Stock (TPST) Company Profile
Name
Tempest Therapeutics Inc
Sector
Industry
Phone
415-798-8589
Address
2000 SIERRA POINT PARKWAY, BRISBANE
Compare TPST with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TPST
Tempest Therapeutics Inc
|
7.49 | 26.62M | 0 | -31.11M | -28.18M | -1.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Tempest Therapeutics Inc Stock (TPST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-10-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Apr-10-25 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| Mar-14-24 | Initiated | Scotiabank | Sector Outperform |
| Feb-08-24 | Initiated | Jefferies | Buy |
Tempest Therapeutics Inc Stock (TPST) Latest News
How institutional ownership impacts Tempest Therapeutics Inc. stockFree AI Driven Stock Trend Forecast - Newser
Is Tempest Therapeutics Inc. stock bottoming outFree Price Action Based Buy Opportunity List - Newser
What makes Tempest Therapeutics Inc. stock price move sharplyTrading Volume Anomaly Summary and Insight - Newser
Is Tempest Therapeutics Inc. trending in predictive chart modelsMarket Stability and Long-Term Growth Outlook - Newser
Can Tempest Therapeutics Inc. hit a new high this monthBear Market Safe Zone Technical Analysis - Newser
Predicting Tempest Therapeutics Inc. trend using moving averagesStrategy Builder for Growth Focused Traders - Newser
Understanding Tempest Therapeutics Inc.’s price movementROI Focused Setup With Drawdown Analysis - Newser
What is Tempest Therapeutics Inc. company’s growth strategyFree Stock Insights For Every Investor - jammulinksnews.com
Multi factor analysis applied to Tempest Therapeutics Inc.Weekly Stock Market Strategy Summary - Newser
Tempest Therapeutics Inc. Company’s Quarterly Earnings Growth: What the Numbers SaySwing Trade Entry and Exit Point Analysis - Newser
How Tempest Therapeutics Inc. stock performs during market volatilityFree Daily Top Performing Stock Insights - Newser
Tempest Therapeutics Inc. Chart Enters High Volatility ZoneCommunity Verified Stock Suggestions Drive Volume - metal.it
Why Tempest Therapeutics Inc. stock attracts strong analyst attentionConservative Investment Setup and Risk Analysis - Newser
What Technical Tools Say About Tempest Therapeutics Inc. RecoveryReal-Time Market Sentiment Tracking Gains Momentum - metal.it
Published on: 2025-07-29 22:28:14 - metal.it
How Interest Rate Changes Impact Tempest Therapeutics Inc. Stock PerformanceTechnical Trade Plan with Entry Checklist - Newser
Tempest Therapeutics (NASDAQ:TPST) Trading Up 4.1% – What’s Next? - Defense World
Published on: 2025-07-29 01:25:48 - metal.it
Published on: 2025-07-28 18:42:16 - metal.it
Should I hold or sell Tempest Therapeutics Inc. stock in 2025High-velocity capital appreciation - jammulinksnews.com
How does Tempest Therapeutics Inc. generate profit in a changing economyFind market-beating stocks for your portfolio - jammulinksnews.com
Does Tempest Therapeutics Inc. stock perform well during market downturnsUnlock expert trading strategies for growth - jammulinksnews.com
What is the dividend policy of Tempest Therapeutics Inc. stockFree Stock Insights For Every Investor - jammulinksnews.com
Is it the right time to buy Tempest Therapeutics Inc. stockBreakout portfolio performance - jammulinksnews.com
How many analysts rate Tempest Therapeutics Inc. as a “Buy”Build wealth steadily with proven investment techniques - jammulinksnews.com
How Tempest Therapeutics Inc. stock reacts to Fed policy changesUnprecedented profits - jammulinksnews.com
What analysts say about Tempest Therapeutics Inc. stockTriple-digit growth rates - PrintWeekIndia
Is Tempest Therapeutics Inc. a good long term investmentSuperior stock growth - Autocar Professional
Tempest Therapeutics Inc. Stock Analysis and ForecastExplosive wealth accumulation - jammulinksnews.com
Tempest Therapeutics Inc Stock (TPST) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):